News

Oppenheimer Lowered PT on Braze, Inc (BRZE), Kept an Outperform Rating
Braze, Inc. (NASDAQ:BRZE) is one of the Best 52-Week Low Stocks to Buy According to Analysts. On June 24, Oppenheimer lowered ...
Fintel on MSN19h
Oppenheimer Initiates Coverage of MBX Biosciences (MBX) with Outperform Recommendation
Fintel reports that on July 16, 2025, Oppenheimer initiated coverage of MBX Biosciences (NasdaqGS:MBX) with a Outperform recommendation. Analyst Price Forecast Suggests 207.65% Upside As of June 20, ...